CYCN Stock Analysis: Buy, Sell, or Hold?
CYCN - Cyclerion Therapeutics, Inc. Common Stock
$3.83
0.01 (0.26%)
▲
5d:
+10.06%
30d:
+19.31%
90d:
+32.53%
HOLD
MODERATE Confidence
Analysis Updated: Jul 14, 2026 12:00 AM ET
Earnings: Aug 04, 2026
19d
Get Alerted When CYCN Hits Your Target Price
Join 10,000+ traders who never miss a move
You're in! Check your email to confirm and set your target price.
100% Free
No spam, ever
Unsubscribe anytime
Interactive Price Chart (1 Month)
Loading chart...
Loading historical data...
Bottom Line:
📊 HOLD: CYCN shows balanced signals. Fine to hold or accumulate slowly. Monitor for clearer direction.
📊 HOLD: CYCN shows balanced signals. Fine to hold or accumulate slowly. Monitor for clearer direction.
In-depth Analysis How we analyze
Valuation Analysis: CYCN is currently trading at $3.83, which is considered extended relative to its 30-day fair value range of $3.08 to $3.60.
Technical Outlook: Technically, CYCN is in a uptrend. The price is approaching resistance at $3.28. A breakout above this level would be a bullish signal, while rejection here could lead to consolidation.
Market Sentiment: CYCN has a strong technical setup (75/100), with favorable trendlines, momentum, and price action for short-term traders. Wall Street analysts see significant upside, with an average price target of $8.00 (+108.9%). The stock is fairly positioned - fine to hold existing positions or accumulate slowly on dips, but not an urgent buy.
Technical Outlook: Technically, CYCN is in a uptrend. The price is approaching resistance at $3.28. A breakout above this level would be a bullish signal, while rejection here could lead to consolidation.
Market Sentiment: CYCN has a strong technical setup (75/100), with favorable trendlines, momentum, and price action for short-term traders. Wall Street analysts see significant upside, with an average price target of $8.00 (+108.9%). The stock is fairly positioned - fine to hold existing positions or accumulate slowly on dips, but not an urgent buy.
Quick Decision Summary
Current Position
EXTENDED
Historical Trading Range
$3.08 -
$3.60
Company Quality Score
55/100
(HOLD)
Volume Confirmation
HIGH
Confidence Score
57.9%
All Signals
- BEARISH: Price extended above range (+6.4% above its trading range)
- BULLISH: Strong technical setup (75/100)
- BULLISH: High volume confirmation
- BULLISH: Trading 108.9% below Wall St target ($8.00)
Trading Range Analysis
30-Day Trading Range
$3.08 -
$3.60
Current vs Trading Range
EXTENDED
Support & Resistance Levels
Support Level
$2.96
Resistance Level
$3.28
Current Trend
Uptrend
Technical data as of
Jun 9, 2026
Fundamental Context
Forward P/E (Next Year Est.)
-3.87
Wall Street Target
$8.00
(+108.9%)
Revenue Growth (YoY)
-43.2%
Profit Margin
-264.7%
Share & Embed Analysis
Last updated: July 14, 2026 10:21 PM ET
Data refreshes hourly during market hours. Next update: 11:21 PM
Data refreshes hourly during market hours. Next update: 11:21 PM
🔥 Top Stocks Breaking Out Now
| Ticker | Score | Recommendation | Change % |
|---|
Technical Signals Check
Is CYCN showing a specific setup today?
Insider Activity (6 Months)
0
Buys
0
Sells
0
Net
NEUTRAL
Top Rated Biotechnology Stocks
Top-rated stocks in Biotechnology by analyst ratings.
| Stock | Analyst Consensus | Analyst Target | Tradestie Score |
|---|---|---|---|
|
VRTX
Vertex Pharmaceuticals I… |
BUY
34 analysts |
$555 | 51 HOLD |
|
XENE
Xenon Pharmaceuticals Inc |
STRONG BUY
19 analysts |
$81 | 55 HOLD |
|
CYTK
Cytokinetics Inc |
STRONG BUY
21 analysts |
$108 | 57 HOLD |
|
MLTX
MoonLake Immunotherapeut… |
STRONG BUY
16 analysts |
$28 | 62 BUY |
|
ORIC
Oric Pharmaceuticals Inc |
STRONG BUY
12 analysts |
$20 | 63 BUY |
